Igg antibody responses and immune persistence of two doses of bbibp-corv vaccine or coronavac vaccine in people living with hiv (plwh) in shenzhen, china

HIGHLIGHTS

• who: Guang Zeng et al. from the Living with HIV (PLWH) in Shenzhen, China School of Public Health, University of South China, Hengyang, China have published the research: IgG Antibody Responses and Immune Persistence of Two Doses of BBIBP-CorV Vaccine or CoronaVac Vaccine in People Living with HIV (PLWH) in Shenzhen, China, in the Journal: Vaccines 2022, 10, 880. of 10/08/2021
• what: The aim of this study was to preliminarily evaluate the immunogenicity and persistence of inactivated SARS-CoV-2 vaccines in PLWH in the real world. In this study, peripheral venous . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.